<SEC-DOCUMENT>0001157523-17-002653.txt : 20171006
<SEC-HEADER>0001157523-17-002653.hdr.sgml : 20171006
<ACCEPTANCE-DATETIME>20171005180042
ACCESSION NUMBER:		0001157523-17-002653
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20171005
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171006
DATE AS OF CHANGE:		20171005

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			USANA HEALTH SCIENCES INC
		CENTRAL INDEX KEY:			0000896264
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				870500306
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35024
		FILM NUMBER:		171125410

	BUSINESS ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336
		BUSINESS PHONE:		8019547100

	MAIL ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		STREET 2:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	USANA INC
		DATE OF NAME CHANGE:	19930125
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a51695304.htm
<DESCRIPTION>USANA HEALTH SCIENCES, INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2017 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <p style="text-align: center">
      <br>
      <font style="font-family: Times New Roman; font-size: 14pt"><b>UNITED
      STATES</b></font><br><br><font style="font-family: Times New Roman; font-size: 14pt"><b>SECURITIES
      AND EXCHANGE COMMISSION</b></font><br><br><font style="font-family: Times New Roman; font-size: 12pt"><b>WASHINGTON,
      D.C. 20549</b></font><br><font style="font-family: Times New Roman; font-size: 12pt">______________</font><br>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 14pt"><b>FORM 8-K</b></font><br><font style="font-family: Times New Roman; font-size: 12pt">______________</font><br>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 12pt"><b>CURRENT
      REPORT</b></font><br><br><font style="font-family: Times New Roman; font-size: 10pt">Pursuant
      to Section 13 or 15(d) of</font><br><br>t<font style="font-family: Times New Roman; font-size: 10pt">he
      Securities Exchange Act of 1934</font><br><br><font style="font-family: Times New Roman; font-size: 10pt">Date
      of Report (Date of Earliest Event Reported):</font><br><font style="font-family: Times New Roman; font-size: 10pt">October
      5, 2017</font><br><br><font style="font-size: 24pt"><b>USANA HEALTH
      SCIENCES, INC.</b></font><br><font style="font-family: Times New Roman; font-size: 10pt">(Exact
      name of registrant as specified in its charter)</font><br><br>Utah<br>(State
      or other jurisdiction of incorporation)<br><br>
    </p>
    <div style="text-align:center">
    <table cellspacing="0" style="font-family: Times New Roman; width: 100%; font-size: 10pt; margin-left:auto;margin-right:auto; margin-bottom: 10.0px">
      <tr>
        <td valign="bottom" style="padding-right: 0.0px; padding-left: 0.0px; width: 40%; white-space: nowrap; text-align: center">
          <p style="margin-top: 0px; margin-bottom: 0px">
            001-35024
          </p>
        </td>
        <td style="width: 20%">
          &#160;
        </td>
        <td valign="bottom" style="padding-right: 0.0px; padding-left: 0.0px; width: 40%; white-space: nowrap; text-align: center">
          <p style="margin-top: 0px; margin-bottom: 0px">
            87-0500306
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; width: 40%; text-align: center">
          <p style="margin-top: 0px; margin-bottom: 0px">
            (Commission File No.)
          </p>
        </td>
        <td style="width: 20%">

        </td>
        <td valign="top" style="padding-left: 0.0px; width: 40%; text-align: center">
          <p style="margin-top: 0px; margin-bottom: 0px">
            (IRS Employer Identification
          </p>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="padding-left: 0.0px; width: 40%; text-align: center">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td style="width: 20%">

        </td>
        <td valign="bottom" style="padding-left: 0.0px; width: 40%; text-align: center">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Number)
          </p>
        </td>
      </tr>
    </table>
    </div>
    <div style="text-align:center">
    <table cellspacing="0" style="font-family: Times New Roman; width: 100%; font-size: 10pt; margin-left:auto;margin-right:auto; margin-bottom: 10.0px">
      <tr>
        <td valign="bottom" style="padding-left: 0.0px; text-align: center">
          <p style="margin-top: 0px; margin-bottom: 0px">
            3838 West Parkway Boulevard<br>Salt Lake City, Utah 84120
          </p>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="padding-left: 0.0px; text-align: center">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <font style="font-family: Times New Roman; font-size: 10pt">(Address
            of principal executive offices,</font> <font style="font-family: Times New Roman; font-size: 10pt">Zip
            Code)</font>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: center">
          <p style="font-family: Times New Roman; font-size: 10pt">
            <font style="font-family: Times New Roman; font-size: 10pt">Registrant&#8217;s
            telephone number, including area code: </font><font style="font-size: 10pt">(801)
            954-7100</font>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>
      <font style="font-family: Times New Roman; font-size: 10pt">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions:</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font>
    </p>
    <p>
      Indicate by check mark whether the registrant is an emerging growth
      company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
      &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR
      &#167;240.12b-2).<br>
    </p>
    <p>
      Emerging Growth Company <font style="font-family: Arial Unicode MS; font-size: 12pt">&#8414;</font><br>
    </p>
    <p>
      If an emerging growth company, indicate by check mark if the registrant
      has elected not to use the extended transition period for complying with
      any new or revised financialaccounting standards provided pursuant to
      Section 13(a) of the Exchange Act. <font style="font-family: Arial Unicode MS; font-size: 12pt">&#8414;</font>
    </p>
    <div style="margin-left: 0pt; width: 100%; margin-right: 0pt; text-indent: 0pt; margin-bottom: 10pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      <b>Item 5.02, Departure of Directors or Principal Officers; Election of
      Directors; Appointment of Principal Officers</b>
    </p>
    <p>
      Effective as of October 5, 2017, the Board of Directors of USANA Health
      Sciences, Inc. (the &#8220;Company&#8221;) acted unanimously to appoint Mr. J. Scott
      Nixon as an additional director of the Company, for an initial term
      expiring at the Company&#8217;s 2018 Annual Meeting of Shareholders. Mr. Nixon
      has not been appointed to any Committees of the Board of Directors at
      this time.
    </p>
    <p>
      Mr. Nixon, a certified public accountant, retired in 2015 as a partner
      with PricewaterhouseCoopers LLP (PwC) where he spent over 31 years in
      various roles including Office Managing Partner and engagement partner
      over public and private companies in many industries. His career
      involved providing audit and business advisory services. Mr. Nixon was
      involved in numerous complex filings with the Securities and Exchange
      Commission on behalf of his clients. In 2007, Mr. Nixon returned from a
      four-year assignment in S&#227;o Paulo, Brazil where he represented various
      interests of the PwC global firm to the 18-member firms in South and
      Central America, and led the implementation and compliance of the
      Sarbanes-Oxley requirements in those countries. Mr. Nixon has served as
      a member of the Board of Directors of ProLung, Inc. since November 2016.
      He also serves on several boards of directors for private and non-profit
      companies, including Deseret Trust Company as a member of the Audit and
      Executive Committees since 2015 and Utah State University Board of
      Trustees, as Chairman of the Audit Committee since 2011. Mr. Nixon is
      currently a Trustee, Vice Chairman and a member of the Executive
      Committee of MountainWest Capital Network and is a National Association
      of Corporate Directors (NACD) Governance Fellow. He holds both a BA and
      Master of Accounting from Utah State University.
    </p>
    <p style="white-space: nowrap">
      <b>Item&#160;9.01 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</b>
    </p>
    <p style="white-space: nowrap">
      <b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b>(d)&#160;&#160;Exhibits
    </p>
    <p style="white-space: nowrap">
      <a href="a51695304ex99_1.htm">Exhibit 99.1</a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="a51695304ex99_1.htm">Press
      release issued by USANA Health Sciences, Inc. dated October 5, 2017
      (furnished herewith).</a>
    </p>
    <div style="margin-left: 0pt; width: 100%; margin-right: 0pt; text-indent: 0pt; margin-bottom: 10pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <br>
      <font style="font-family: Times New Roman; font-size: 10pt"><b>SIGNATURES</b></font><br>
    </p>
    <p>
      Pursuant to the requirements of the Securities Exchange Act of 1934, the
      registrant has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.
    </p>
    <p style="text-align: justify; text-indent: 30.0px">

    </p>
<div style="text-align:left">
    <table cellspacing="0" style="font-family: Times New Roman; width: 100%; font-size: 10pt; margin-bottom: 10.0px">
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="padding-left: 0.0px; width: 40%; text-align: left">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>USANA HEALTH SCIENCES, INC.</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="padding-left: 0.0px; width: 40%; text-align: left">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="padding-left: 0.0px; width: 40%; text-align: left">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; width: 5%; text-align: left">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="padding-left: 0.0px; width: 55%; text-align: left">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="padding-left: 0.0px; width: 40%; text-align: left">
          <p style="margin-top: 0px; margin-bottom: 0px">
            By:<b> </b>/s/ Douglas Hekking
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="padding-left: 0.0px; width: 40%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="padding-left: 0.0px; width: 40%; text-align: left">
          <p style="margin-top: 0px; margin-bottom: 0px">
            G. Douglas Hekking, Chief Financial Officer
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="padding-left: 0.0px; width: 40%; text-align: left">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="padding-left: 0.0px; width: 40%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; width: 5%; text-align: left">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Date:
          </p>
        </td>
        <td valign="top" style="padding-left: 0.0px; width: 55%; text-align: left">
          <p style="margin-top: 0px; margin-bottom: 0px">
            October 5, 2017
          </p>
        </td>
        <td style="width: 40%">

        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <p style="text-align: center">

    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a51695304ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2017 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 8pt">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 12pt"><b>USANA
      Health Sciences Announces Appointment of J. Scott Nixon to Board of
      Directors</b></font>
    </p>
    <p>
      SALT LAKE CITY--(BUSINESS WIRE)--October 5, 2017--USANA Health Sciences,
      Inc. (NYSE: USNA) today announced the appointment of J. Scott Nixon to
      the company&#8217;s board of directors effective October 5, 2017. Mr. Nixon
      joins the board as an independent director and brings a wealth of
      accounting, finance, and corporate strategy expertise. The USANA board
      now has eight members, five of whom are independent.
    </p>
    <p>
      Myron W. Wentz, Ph.D., Chairman of the Board, commented, &#8220;I&#8217;m very
      pleased to welcome Scott Nixon to our board. He brings significant
      finance, accounting, and industry experience &#8211; with over three decades
      in international and domestic audit and business advisory services
      across a variety of industries, including direct selling &#8211; which will
      provide tremendous value to USANA.&#8221;
    </p>
    <p>
      Mr. Nixon commented, &#8220;Having spent several years working directly with
      USANA, I am very familiar with the company&#8217;s business and the strong
      corporate values and commitment to health and nutrition that make it a
      leader in its industry. I am honored to accept a seat on the company&#8217;s
      board of directors and look forward to contributing to USANA&#8217;s future
      success.&#8221;
    </p>
    <p>
      <b>About Scott Nixon</b>
    </p>
    <div style="margin-left: 0pt; width: 100%; margin-right: 0pt; text-indent: 0pt; margin-bottom: 10pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      Mr. Nixon, a certified public accountant, retired in 2015 as a partner
      with PricewaterhouseCoopers LLP (&#8220;PwC&#8221;) where he spent over 31 years in
      various roles including office managing partner and engagement partner
      over public and private companies in many industries. His career
      involved providing audit and business advisory services. Mr. Nixon was
      involved in numerous complex filings with the Securities and Exchange
      Commission on behalf of his clients. In 2007, Mr. Nixon returned from a
      four-year assignment in S&#227;o Paulo, Brazil where he represented various
      interests of the PwC global firm to the 18 member firms in South and
      Central America, and led the implementation of the Sarbanes-Oxley
      requirements in those countries.
    </p>
    <p>
      Mr. Nixon serves on several boards of directors, including: (i) ProLung,
      Inc., where he also serves as Chairman of the Audit Committee and a
      member of the Compensation Committee; (ii) Deseret Trust Company, where
      he also serves as a member of the Audit and Executive Committees; (iii)
      Utah State University Board of Trustees, where he also serves as
      Chairman of the Audit Committee; and (iv) two other nonprofit boards of
      directors. Mr. Nixon is a National Association of Corporate Directors
      (NACD) Governance Fellow, the highest standard of credentialing for
      directors and governance professionals. He holds both a Bachelor of Arts
      and Master of Accounting from Utah State University.
    </p>
    <p>
      <b>About USANA</b>
    </p>
    <p>
      USANA develops and manufactures high-quality nutritional supplements,
      healthy foods and personal care products that are sold directly to
      Associates and Preferred Customers throughout the United States, Canada,
      Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea,
      Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the
      United Kingdom, Thailand, France, Belgium, Colombia and Indonesia. More
      information on USANA can be found at <u>www.usana.com</u>.
    </p>
    <p>
      CONTACT:<br>USANA Health Sciences, Inc.<br>Investors contact:<br>Patrique
      Richards, 801-954-7961<br>Investor Relations<br><u>investor.relations@us.usana.com</u><br>or<br>Media
      contact:<br>Dan Macuga, 801-954-7280<br>Public Relations
    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
